1. Home
  2. CAPR vs CARS Comparison

CAPR vs CARS Comparison

Compare CAPR & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

N/A

Current Price

$7.60

Market Cap

584.9M

Sector

Health Care

ML Signal

N/A

Logo Cars.com Inc.

CARS

Cars.com Inc.

N/A

Current Price

$12.31

Market Cap

546.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
CAPR
CARS
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
584.9M
546.6M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
CAPR
CARS
Price
$7.60
$12.31
Analyst Decision
Buy
Hold
Analyst Count
10
7
Target Price
★ $27.25
$14.36
AVG Volume (30 Days)
★ 4.2M
880.5K
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.62
Revenue
N/A
★ $723,239,000.00
Revenue This Year
N/A
$0.41
Revenue Next Year
$85.77
$2.23
P/E Ratio
★ N/A
$19.92
Revenue Growth
N/A
★ 0.57
52 Week Low
$2.96
$7.40
52 Week High
$40.37
$14.02

Technical Indicators

Market Signals
Indicator
CAPR
CARS
Relative Strength Index (RSI) 48.38 52.98
Support Level $7.78 $10.71
Resistance Level $10.62 $13.22
Average True Range (ATR) 1.18 0.67
MACD -0.11 -0.10
Stochastic Oscillator 19.61 34.37

Price Performance

Historical Comparison
CAPR
CARS

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About CARS Cars.com Inc.

Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.

Share on Social Networks: